2022
Variability in 30-day major amputation rates following endovascular peripheral vascular intervention for critical limb ischemia
Provance JB, Spertus JA, Jones PG, Hoffman MA, Bunte MC, Vogel TR, Mena-Hurtado C, Smolderen KG. Variability in 30-day major amputation rates following endovascular peripheral vascular intervention for critical limb ischemia. Vascular Medicine 2022, 27: 350-357. PMID: 35603755, DOI: 10.1177/1358863x221098097.Peer-Reviewed Original ResearchConceptsPeripheral vascular interventionsCritical limb ischemiaMedian risk ratioEndovascular peripheral vascular interventionsMajor amputation ratePatient-level factorsAmputation ratePVI procedureLimb ischemiaRisk ratioVascular interventionsNational electronic health record databaseElectronic health record databasePredictors of amputationRate of amputationMixed effects Poisson regression modelHealth record databaseEffects Poisson regression modelPoisson regression modelsCLI carePrevious amputationClinical factorsCLI treatmentBlack raceDiagnosis codes
2020
Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease Meta-Analysis of Randomized Trials
Atti V, Gwon Y, Narayanan MA, Garcia S, Sandoval Y, Brilakis ES, Basir MB, Turagam MK, Khandelwal A, Mena-Hurtado C, Mamas MA, Abbott JD, Bhatt DL, Velagapudi P. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease Meta-Analysis of Randomized Trials. JACC Cardiovascular Interventions 2020, 13: 1571-1582. PMID: 32646699, DOI: 10.1016/j.jcin.2020.04.055.Peer-Reviewed Original ResearchConceptsMultivessel percutaneous coronary interventionST-segment elevation myocardial infarctionPercutaneous coronary interventionElevation myocardial infarctionMultivessel coronary artery diseaseCulprit vesselCoronary artery diseaseCause mortalityMyocardial infarctionArtery diseaseControlled TrialsRisk ratioLower riskUnderwent multivessel PCIVersus Culprit-Only RevascularizationCulprit-only revascularizationMultivessel PCI strategyPrimary efficacy outcomeCochrane Central RegisterContrast-induced nephropathyConfidence intervalsRandom-effects modelWeb of ScienceMajor bleedingCardiovascular mortality